Keywords: galileo, closes, 31m, financing, privately-held, biotechnology, company

Galileo closes $31M financing

Article | 05 May 2003

Privately-held US biotechnology company Galileo Pharmaceuticals, whichis focused on drug development targeting redox signaling pathways, has announced the closing of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Johnson & Johnson

Novartis

Go to company listing